Denis R Joanisse Selected Research

Denis R Joanisse Research Topics

Disease

9	Obesity 04/2024 - 05/2007
9	Insulin Resistance 11/2020 - 11/2003
6	Body Weight (Weight, Body) 11/2020 - 07/2003
4	Inflammation (Inflammations) 04/2024 - 09/2016
4	Weight Loss (Weight Reduction) 11/2011 - 03/2002
3	Ischemia 01/2018 - 05/2011
2	Hypertrophy 03/2024 - 12/2022
2	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 12/2023 - 01/2023
2	Arterial Occlusive Diseases (Arterial Occlusive Disease) 09/2016 - 01/2016
2	Chronic Obstructive Pulmonary Disease (COPD) 11/2010 - 08/2007
1	Metabolically Benign Obesity 04/2024
1	Overweight 04/2024
1	Fibrosis (Cirrhosis) 05/2022
1	Morbid Obesity 05/2022
1	Glucose Intolerance 09/2016
1	Type 2 Diabetes Mellitus (MODY) 12/2015
1	Muscular Diseases (Myopathy) 12/2015
1	Myotoxicity 12/2015
1	Dyslipidemias (Dyslipidemia) 12/2015
1	Reperfusion Injury 05/2011
1	Stroke (Strokes) 10/2009
1	Infarction (Infarctions) 10/2009
1	Renal Insufficiency (Renal Failure) 10/2009
1	Fatigue 03/2008
1	Hypoadiponectinemia 02/2008
1	Hypertriglyceridemia 10/2007
1	Muscular Atrophy (Muscle Atrophy) 08/2007
1	Abdominal Obesity 05/2007
1	Hyperlipidemias (Hyperlipidemia) 05/2007
1	Hypoxia (Hypoxemia) 03/2006
1	Hypertension (High Blood Pressure) 11/2003

Drug/Important Bio-Agent (IBA)

8	LeptinIBA 04/2024 - 11/2011
7	Insulin (Novolin)FDA Link 04/2024 - 11/2003
7	AdiponectinIBA 04/2024 - 02/2008
6	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 09/2015
6	EnzymesIBA 11/2011 - 03/2002
4	LipidsIBA 04/2024 - 02/2008
4	Citrate (si)-Synthase (Synthase, Citrate)IBA 09/2015 - 03/2002
4	PhosphofructokinasesIBA 01/2010 - 03/2002
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2023 - 12/2015
3	Proteins (Proteins, Gene)FDA Link 12/2016 - 08/2007
3	Messenger RNA (mRNA)IBA 11/2011 - 08/2007
3	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2010 - 03/2002
2	Lipoproteins (Lipoprotein)IBA 04/2024 - 11/2020
2	Triglycerides (Triacylglycerol)IBA 11/2020 - 10/2007
2	salicylhydroxamic acid (SHAM)IBA 01/2018 - 01/2016
2	Hemoglobins (Hemoglobin)IBA 09/2016 - 01/2016
2	antineoplaston A10 (A 10)IBA 11/2011 - 01/2010
2	GlycogenIBA 01/2010 - 11/2003
2	11-beta-Hydroxysteroid Dehydrogenase Type 1IBA 10/2007 - 05/2007
2	GlucocorticoidsIBA 10/2007 - 05/2007
1	Vitamin D FDA LinkGeneric 12/2023
1	Biomarkers (Surrogate Marker)IBA 05/2022
1	Sterol Regulatory Element Binding Protein 1IBA 05/2022
1	Plasminogen Activator Inhibitor 1IBA 05/2022
1	HDL CholesterolIBA 11/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2020
1	AdipokinesIBA 11/2020
1	Monoamine Oxidase (MAO)IBA 11/2020
1	Apolipoproteins D (Apo D)IBA 01/2018
1	Perilipin-5IBA 12/2016
1	deoxyhemoglobinIBA 09/2016
1	Natriuretic PeptidesIBA 12/2015
1	Adenosine Triphosphatases (ATPase)IBA 11/2011
1	Protein Isoforms (Isoforms)IBA 11/2011
1	Hormones (Hormone)IBA 11/2011
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 03/2008
1	Lactic Acid (Lactate)FDA LinkGeneric 03/2008
1	Monocarboxylic Acid TransportersIBA 03/2008
1	11-beta-Hydroxysteroid Dehydrogenases (11beta Hydroxysteroid Dehydrogenase)IBA 10/2007
1	Peptide Initiation Factors (Initiation Factor)IBA 08/2007
1	Glycogen Synthase (Synthase I)IBA 08/2007
1	Glycogen Synthase Kinase 3 betaIBA 08/2007
1	Sucrose (Saccharose)IBA 05/2007
1	Erythropoietin FDA Link 03/2006
1	BuffersIBA 03/2006
1	Creatine Kinase (Creatine Phosphokinase)IBA 09/2003
1	3-Hydroxyacyl-CoA DehydrogenaseIBA 09/2003
1	Adenosine Triphosphate (ATP)IBA 07/2003
1	Coenzyme A (CoA)IBA 03/2002
1	Oxidoreductases (Dehydrogenase)IBA 03/2002
1	Environmental Pollutants (Pollutants, Environmental)IBA 03/2002
1	Chlorinated HydrocarbonsIBA 03/2002

Therapy/Procedure

1	Resistance Training 04/2024
1	Bariatric Surgery 05/2022
1	Glycemic Control 12/2015
1	Injections 11/2011
1	Therapeutics 05/2011
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 05/2011
1	Length of Stay 10/2009
1	Artificial Respiration (Mechanical Ventilation) 10/2009